Campus alert status is yellow: For the latest campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search
Search Close Search
  • Program Slider
Page Menu

Chief's Welcome

Meyer.png

The Division of Cardiovascular Medicine is directed by:

Theo Meyer, MD, Interim Division Chief

Welcome to the Division of Cardiovascular Medicine. I am proud to be part of a talented division comprised of more than 35 world-class colleagues committed to doing exceptional work in cardiovascular medicine. Our diverse faculty provide both breadth and depth in their experience and expertise, with leaders spanning general cardiology and subspecialty disciplines. 

Our physicians perform approximately 34,000 clinic visits annually are invested in academic training all while maintaining a robust portfolio of clinical trials that provide our patients with the opportunity to experience the latest in new treatments. 

As an academic division, we also are committed to bringing cutting-edge technology and treatment to our patient community. Therefore, we have specialists in critical care, interventional cardiology, electrophysiology, prevention, pulmonary hypertension, and heart failure available at all times. We are a national leader in myocardial infarction care and have the most advanced catheterization laboratory in the Commonwealth. State-of-the-art programs in catheter-based heart valve treatment, a center for durable mechanical circulatory support, arrhythmia ablation, and outpatient coronary stent implantation have established us as the region’s leading provider of cutting-edge cardiovascular care. 

We graduate six next-generation cardiovascular specialists annually. We also provide community forums on common cardiovascular conditions and have patient education and support groups related to heart device implants, arrhythmias, and heart failure treatment.

As faculty in the medical school, we are also committed to advancing knowledge in the cardiovascular arena. Consequently, we have internationally recognized programs in vascular biology, thrombosis, gene therapy, cardiac development, and the role of micro RNA in cardiovascular disease. We also maintain a robust portfolio of clinical trials that provide our patients with the opportunity to experience the latest in new treatments.

Browse the sections of this website to learn more about our Division and the opportunities we offer.